Gen Z are shifting their spending priorities, with fitness and health now outranking traditional leisure habits such as takeaways and streaming services. According to new figures from the Gym Group,
Fitnesses and Wellbeing
17Articles
Applied Nutrition, a protein shake producer backed by JD Sports and high-profile investor Coleen Rooney, has celebrated its inaugural year as a publicly-listed company with results that outpace market expectations.
Strava, the global exercise tracking platform, has seen its valuation soar to $2.2 billion following its acquisition of the London-based running app Runna. This marks the first time since November
The nation’s beloved fitness coach, Joe Wicks, is embarking on an ambitious mission to revolutionise workplace wellness through his groundbreaking “movement hour” initiative. The programme, launching this month, aims to
The low-cost fitness operator, The Gym Group, has delivered impressive financial results for the year ending December 2024, surpassing market expectations and setting the stage for accelerated expansion plans. Membership
The UK’s leading budget gym operators are aggressively expanding their footprint into smaller towns and retail parks, marking a significant shift in their growth strategy. PureGym, The Gym Group, and
Recent breakthrough research from Denmark’s Aarhus University has sparked significant market interest in the pharmaceutical sector, particularly concerning exercise mimetics. The discovery of LaKe, a compound purported to replicate the
AstraZeneca’s acquisition of a cancer drug for up to $1billion has been marred by disappointing results in late-stage trials, causing yet another clinical setback. The FTSE100 company stated that phase
AstraZeneca has suffered a setback after disappointing late-stage results from a lung cancer drug that was closely monitored. The FTSE-100 pharmaceutical company showed its confidence in Dato-DXd when it presented
Experts have predicted that weight-loss medicines will see a boom in popularity, now that the first generic versions are available at lower prices than the original drugs. Media-dubbed “skinny jabs”,
Another week of fascinating developments in the field of artificial intelligence. OpenAI, based in San Francisco, unveiled a new model that can translate languages in real-time and tutor children in
The drug has been in the news for a number of years, firstly as a treatment for type 2 diabetics and then as an aid to weight loss. Semaglutide, also
Novo Nordisk wants to increase the use of its blockbuster treatments. It is testing their weight loss drugs to see if they reduce alcohol consumption and treat alcoholic hepatitis. The
The new weight-loss jab outperforms its competitors, including Ozempic. It helps obese patients lose four stone in under a year. Retatrutide acts on three receptors in the mind, “turbocharging”, calorie
GSK’s full-year profits forecasts have been boosted by strong sales of an asthma medicine as well as a blockbuster vaccine for shingles. The FTSE 100 Pharmaceuticals Company posted sales of
Philips has settled lawsuits in the United States over night-time breathing device recalls for $1.1 billion. The Dutch medical technology company stated that the resolution will end the uncertainty caused
- 1
- 2
